Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Cleveland Biolabs, Inc.
(NQ:
CBLI
)
1.660
USD
+0.020 (+1.22%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Cleveland Biolabs, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Cleveland BioLabs and Incuron Announce CBL0102 Orphan Drug Status for Hepatocellular Carcinoma
October 02, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs (CBLI) Recieves FDA Minutes and Advice Letter for Entolimod
October 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7759427 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Receives FDA Meeting Minutes and Advice Letter on Clinical Protocol for Development of Entolimod(TM) (CBLB502) as Radiation Countermeasure
October 01, 2012
from
GlobeNewswire News Releases
Unusual 11 Mid-Day Movers 09/13: (CUR) (CBLI) (PMFG) Higher; (CCRT) (PSTI) (BPI) Lower
September 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7725543 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland Bio (CBLI) Gets Advce Letter from FDA for Entolimod as Radiation Countermeasure
September 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7713292 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Receives FDA Agreement on Pivotal Animal Efficacy Studies for Development of CBLB502 (Entolimod(TM)) as Radiation Countermeasure
September 10, 2012
from
GlobeNewswire News Releases
Watch The Weekly Trend ( CBLI, CCRN, CNO, CONN )
September 06, 2012
Los Angelas, CA -- (SBWIRE) -- 09/06/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks....
Read More
from
SBWire - Latest Press Releases
Cleveland BioLabs to Present at Rodman and Renshaw 14th Annual Healthcare Conference
September 04, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs to Present at 2012 Wedbush Lifesciences Management Access Conference
August 08, 2012
from
GlobeNewswire News Releases
Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
August 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7632441 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Reports Second Quarter 2012 Financial Results and Development Progress
August 06, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs (CBLI) Reports Publication of CBLB502 Efficacy as Radiation Countermeasure
August 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7620802 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Announces Publication of Studies Identifying Biomarkers of CBLB502's Efficacy as a Radiation Countermeasure
August 01, 2012
Definition of Biomarkers Key to Animal Rule Development
Read More
from
GlobeNewswire News Releases
Cleveland BioLabs to Report Second Quarter Financial Results and Provide Operational Update on August 6
July 31, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs (CBLI) Signs $4 Million Contract with Russian Ministry of Industry and Trade
July 30, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7613112 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Signs Contract for Approximately $4 Million With Russian Ministry of Industry and Trade for Development of CBLB612
July 30, 2012
Secures Non-Dilutive Funding
Read More
from
GlobeNewswire News Releases
Cancer Prevention Research Publishes Preclinical Studies on Suppression of Breast Cancer Tumor Formation and Progression Using CBL0137
July 02, 2012
from
GlobeNewswire News Releases
Cleveland Bio (Nasdaq: CBLI) and Incuron Announce Positive Study Results
June 21, 2012
Orlando, FL 6/21/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) and its subsidiary, Incuron, LLC, today announced the results of new studies demonstrating potentially curative effects of...
Read More
from
Street Beat: Articles
Cleveland Bio (Nasdaq: CBLI) and Incuron Announce Positive Study Results
June 21, 2012
Orlando, FL 6/21/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) and its subsidiary, Incuron, LLC, today announced the results of new studies demonstrating potentially curative effects of...
Read More
from
Street Beat: Articles
Cleveland Bio (Nasdaq: CBLI) and Incuron Announce Positive Study Results
June 21, 2012
Orlando, FL 6/21/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) and its subsidiary, Incuron, LLC, today announced the results of new studies demonstrating potentially curative effects of...
Read More
from
Street Beat: Articles
Cleveland BioLabs (CBLI) Says New Studies of CBL0137 Show Possible Curative Effects
June 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7532981 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs and Incuron Announce Results of Studies of CBL0137 in Animal Models of Neuroblastoma
June 21, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs Launches Updated Website
June 18, 2012
from
GlobeNewswire News Releases
Cleveland BioLabs (CBLI) Appoints Yakov Kogan as Permanent CEO
June 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7517271 for the full story.
Read More
from
StreetInsider.com News Articles
Cleveland BioLabs Reports Appointment of CEO and Provides Annual Stockholders' Meeting and Investor Day Updates
June 14, 2012
from
GlobeNewswire News Releases
Traders Get Bullish on Shares of Cleveland Biolabs, Shares Up 10.4% (CBLI)
June 11, 2012
from
Comtex SmarTrend® News Briefs
Unusual 11 Mid-Day Movers 06/05: (AMRS) (WPRT) (BPAX) Higher; (EDS) (SHFL) (CBLI) Lower
June 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7494981 for the full story.
Read More
from
StreetInsider.com News Articles
AimHighProfits Initiates Coverage on CBLI, USEI, NANI, LOVI, GTCP, ADXS
June 05, 2012
Palm Beach Gardens, FL -- (SBWIRE) -- 06/05/2012 -- AimHighProfits, your online source for Penny Stocks, initiates coverage on Cleveland BioLabs Inc (CBLI), U.S. Energy Initiatives Corp.(USEI),...
Read More
from
SBWire - Latest Press Releases
Morning Movers 06/05: (BPAX) (AMRS) (PSUN) Higher; (EDS) (SHFL) (CBLI) (TAST) Lower
June 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7494293 for the full story.
Read More
from
StreetInsider.com News Articles
Biotech Stock to Watch; Cleveland BioLabs (Nasdaq:CBLI)
June 05, 2012
Northern, WI 6/5/12 ( StreetBeat ) -- Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issued a trading alert yesterday for Cleveland...
Read More
from
Street Beat: Articles
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here